Endotronix Inc. reported that the U.S. FDA has granted the company conditional IDE approval to begin the multicenter PROACTIVE-HF trial of the Cordella pulmonary artery pressure sensor system. The nod comes less than a month after Endotronix began enrolling patients in a European study of the device, paving the way for both CE mark and FDA approvals within the next couple of years. Read More
